• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西罗莫司口服增溶制剂的研究进展

Supersaturatable formulations for the enhanced oral absorption of sirolimus.

机构信息

Department of Pharmaceutical Engineering, Inje University, Gimhae, Gyeongnam 621-749, Republic of Korea.

出版信息

Int J Pharm. 2013 Mar 10;445(1-2):108-16. doi: 10.1016/j.ijpharm.2013.01.067. Epub 2013 Feb 8.

DOI:10.1016/j.ijpharm.2013.01.067
PMID:23396259
Abstract

The purpose of this study was to develop supersaturatable formulations for the enhanced solubility and oral absorption of sirolimus. Supersaturatable formulations of hydrophilic polymers and/or surfactants were screened by formulation screening, which is based on solvent casting. The solid dispersion particles in the optimized formulations were prepared by spray drying. The particles were characterized in vitro and in vivo. The most effective supersaturatable formulation found in the formulation screening process was hydroxypropylmethyl cellulose (HPMC)-D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS), followed by HPMC-Sucroester. In addition, the supersaturated state generated from HPMC-TPGS and HPMC-Sucroester 15 particles prepared by spray drying significantly improved the oral absorption of sirolimus in rats. Based on the pharmacokinetic parameters and supporting in vitro supersaturated dissolution data, the enhanced supersaturation properties of sirolimus led to enhanced in vivo oral absorption. In addition, the experimental results from the formulation screening used in our study could be useful for enhancing the bioavailability of sirolimus in preformulation and formulation studies.

摘要

本研究旨在开发可提高西罗莫司溶解度和口服吸收的超饱和制剂。通过基于溶剂浇铸的制剂筛选,筛选出亲水性聚合物和/或表面活性剂的超饱和制剂。通过喷雾干燥制备优化配方中的固体分散颗粒。对颗粒进行了体外和体内的表征。在制剂筛选过程中发现的最有效的超饱和制剂是羟丙甲纤维素(HPMC)-D-α-生育酚聚乙二醇 1000 琥珀酸酯(TPGS),其次是 HPMC-蔗糖酯。此外,喷雾干燥制备的 HPMC-TPGS 和 HPMC-Sucroester 15 颗粒形成的超饱和状态显著提高了西罗莫司在大鼠体内的口服吸收。基于药代动力学参数和支持的体外超饱和溶解数据,西罗莫司增强的超饱和特性导致体内口服吸收增强。此外,我们研究中使用的制剂筛选实验结果可用于增强西罗莫司在预配方和制剂研究中的生物利用度。

相似文献

1
Supersaturatable formulations for the enhanced oral absorption of sirolimus.西罗莫司口服增溶制剂的研究进展
Int J Pharm. 2013 Mar 10;445(1-2):108-16. doi: 10.1016/j.ijpharm.2013.01.067. Epub 2013 Feb 8.
2
Enhanced supersaturation and oral absorption of sirolimus using an amorphous solid dispersion based on Eudragit® e.使用基于尤特奇®E的无定形固体分散体提高西罗莫司的过饱和度和口服吸收。
Molecules. 2015 May 25;20(6):9496-509. doi: 10.3390/molecules20069496.
3
Enhanced solubility and oral absorption of sirolimus using D-α-tocopheryl polyethylene glycol succinate micelles.使用 D-α-生育酚聚乙二醇琥珀酸酯胶束提高西罗莫司的溶解度和口服吸收。
Artif Cells Nanomed Biotechnol. 2013 Apr;41(2):85-91. doi: 10.3109/21691401.2012.742100. Epub 2013 Jan 10.
4
Dissolution and bioavailability of lercanidipine-hydroxypropylmethyl cellulose nanoparticles with surfactant.含表面活性剂的乐卡地平-羟丙基甲基纤维素纳米粒的溶出度与生物利用度
Int J Biol Macromol. 2015 Jan;72:218-22. doi: 10.1016/j.ijbiomac.2014.08.017. Epub 2014 Aug 23.
5
Effect of aminoalkyl methacrylate copolymer E/HCl on in vivo absorption of poorly water-soluble drug.氨基酸烷基甲基丙烯酸盐共聚物 E/HCl 对体内难溶性药物吸收的影响。
Drug Dev Ind Pharm. 2013 Nov;39(11):1698-705. doi: 10.3109/03639045.2012.730525. Epub 2012 Oct 15.
6
Optimized formulation of solid self-microemulsifying sirolimus delivery systems.固体自微乳化西罗莫司给药系统的优化配方。
Int J Nanomedicine. 2013;8:1673-82. doi: 10.2147/IJN.S43299. Epub 2013 Apr 26.
7
Formulation of fast disintegrating tablets of ternary solid dispersions consisting of TPGS 1000 and HPMC 2910 or PVPVA 64 to improve the dissolution of the anti-HIV drug UC 781.由TPGS 1000与HPMC 2910或PVPVA 64组成的三元固体分散体速崩片的制备,以提高抗HIV药物UC 781的溶出度。
Eur J Pharm Sci. 2008 Aug 7;34(4-5):293-302. doi: 10.1016/j.ejps.2008.05.005. Epub 2008 Jul 7.
8
Development of megestrol acetate solid dispersion nanoparticles for enhanced oral delivery by using a supercritical antisolvent process.采用超临界抗溶剂法制备醋酸甲地孕酮固体分散体纳米粒以增强口服给药效果
Drug Des Devel Ther. 2015 Aug 4;9:4269-77. doi: 10.2147/DDDT.S90706. eCollection 2015.
9
Sirolimus formulation with improved pharmacokinetic properties produced by a continuous flow method.通过连续流动法生产的具有改善药代动力学性质的西罗莫司制剂。
Eur J Pharm Biopharm. 2015 Aug;94:135-40. doi: 10.1016/j.ejpb.2015.05.010. Epub 2015 May 21.
10
Soluplus®/TPGS-based solid dispersions prepared by hot-melt extrusion equipped with twin-screw systems for enhancing oral bioavailability of valsartan.采用配备双螺杆系统的热熔挤出法制备的基于Soluplus®/TPGS的固体分散体,用于提高缬沙坦的口服生物利用度。
Drug Des Devel Ther. 2015 May 22;9:2745-56. doi: 10.2147/DDDT.S84070. eCollection 2015.

引用本文的文献

1
Enteric Polymer-Based Amorphous Solid Dispersions Enhance Oral Absorption of the Weakly Basic Drug Nintedanib via Stabilization of Supersaturation.基于肠溶聚合物的无定形固体分散体通过超饱和稳定化增强弱碱性药物尼达尼布的口服吸收。
Pharmaceutics. 2022 Aug 30;14(9):1830. doi: 10.3390/pharmaceutics14091830.
2
Development and Evaluation of Raloxifene-Hydrochloride-Loaded Supersaturatable SMEDDS Containing an Acidifier.含酸化剂的盐酸雷洛昔芬超饱和自微乳化药物递送系统的研制与评价
Pharmaceutics. 2018 Jun 29;10(3):78. doi: 10.3390/pharmaceutics10030078.
3
Development of megestrol acetate solid dispersion nanoparticles for enhanced oral delivery by using a supercritical antisolvent process.
采用超临界抗溶剂法制备醋酸甲地孕酮固体分散体纳米粒以增强口服给药效果
Drug Des Devel Ther. 2015 Aug 4;9:4269-77. doi: 10.2147/DDDT.S90706. eCollection 2015.
4
Improving dissolution and oral bioavailability of pranlukast hemihydrate by particle surface modification with surfactants and homogenization.通过表面活性剂颗粒表面改性和均质化提高半水普仑司特的溶出度和口服生物利用度。
Drug Des Devel Ther. 2015 Jun 24;9:3257-66. doi: 10.2147/DDDT.S87738. eCollection 2015.
5
Design of a gelatin microparticle-containing self-microemulsifying formulation for enhanced oral bioavailability of dutasteride.含明胶微粒的自微乳化制剂设计用于提高度他雄胺的口服生物利用度
Drug Des Devel Ther. 2015 Jun 23;9:3231-8. doi: 10.2147/DDDT.S86458. eCollection 2015.
6
Enhanced supersaturation and oral absorption of sirolimus using an amorphous solid dispersion based on Eudragit® e.使用基于尤特奇®E的无定形固体分散体提高西罗莫司的过饱和度和口服吸收。
Molecules. 2015 May 25;20(6):9496-509. doi: 10.3390/molecules20069496.
7
Preparation and in vivo evaluation of a dutasteride-loaded solid-supersaturatable self-microemulsifying drug delivery system.度他雄胺固体过饱和自微乳化药物递送系统的制备及体内评价
Int J Mol Sci. 2015 May 13;16(5):10821-33. doi: 10.3390/ijms160510821.
8
Formulation, characterization, and in vivo evaluation of celecoxib-PVP solid dispersion nanoparticles using supercritical antisolvent process.采用超临界抗溶剂法制备塞来昔布-PVP 固体分散体纳米粒及其体内评价。
Molecules. 2014 Dec 4;19(12):20325-39. doi: 10.3390/molecules191220325.
9
Fabrication and evaluation of valsartan-polymer- surfactant composite nanoparticles by using the supercritical antisolvent process.采用超临界抗溶剂法制备缬沙坦-聚合物-表面活性剂复合纳米粒及其评价
Int J Nanomedicine. 2014 Nov 7;9:5167-76. doi: 10.2147/IJN.S71891. eCollection 2014.
10
Influence of hydrophilic additives on the supersaturation and bioavailability of dutasteride-loaded hydroxypropyl-β-cyclodextrin nanostructures.亲水添加剂对载度他司特羟丙基-β-环糊精纳米结构的过饱和度和生物利用度的影响。
Int J Nanomedicine. 2013;8:2029-39. doi: 10.2147/IJN.S44795. Epub 2013 May 20.